Dr Lal PathLabs reports 12.2% revenue growth and dividend declaration
after close1 source ↓written by the desknot a recommendation
- and announced
- 280% dividend
Dr Lal PathLabs Limited submitted its Annual Report for FY 2025-26, revealing revenue growth of 12.2% to ₹28,642 million. The company declared a 280% dividend and announced a bonus issue. This performance reflects strong operational efficiency, which may enhance investor sentiment in the healthcare sector.
• Total expenses rose to ₹21,650 million
• Profit before tax reached ₹6,992 million
Immediate market implications include potential positive movements in share price as investors react to the favorable financial results.
Not investment advice. For informational purposes only.